Breast Cancer Screening in Sintra: Mobile Unit Continues in October

ULSASI and LPCC-NRS initiative aims to increase early detection of the disease in two locations within the municipality.

Mobile breast cancer screening unit in Sintra.
AI

Mobile breast cancer screening unit in Sintra.

The Local Health Unit Amadora/Sintra (ULSASI), in partnership with the Portuguese League Against Cancer – Southern Regional Nucleus (LPCC-NRS) and the Sintra Municipal Chamber, is continuing its breast cancer screening throughout October in two new locations within the municipality.

The initiative aims to increase early detection of the disease, with the LPCC Mobile Unit available at strategic locations. Until October 16, screening will take place at the Olival UCSP, in the Health Center's Parking Lot. Subsequently, from October 20 onwards, the unit will be at the Algueirão-Mem Martins UCSP.
Francisca Pulido Valente, a Public Health physician and member of the ULS Amadora/Sintra Screening Team, emphasizes the program's importance. "Breast cancer is the most frequently diagnosed cancer in women. In Portugal, in 2022, 9,017 new cases were diagnosed, representing about one-third of tumors in females. Scientific evidence shows that organized screening is associated with a reduction in mortality," she stated. "The goal of Public Health is not to create fear around the disease. It is to create conditions for women to know their risk and have access to a quality screening program."
Women residing in Sintra, aged between 45 and 74 years, are eligible for screening. Eligibility criteria include having no breast symptoms, not having breast implants, not having undergone a mastectomy, never having had breast cancer, and not being pregnant or breastfeeding.
For more information and contacts, the LPCC-NRS provides the numbers 245 009 299 and 915 999 890, the email rcm.admin@ligacontracancro.pt, or the portal www.ligacontracancro.pt/rcm-q-a/. Interested individuals can also inquire with their Family Team.
Based on information from the official source: ULS Amadora/Sintra (Hospital Prof. Doutor Fernando Fonseca) (08/10/2026)